Zobrazeno 1 - 10
of 95
pro vyhledávání: ''
Autor:
Benyamin Hoseini, Zahra Rahmatinejad, Ladan Goshayeshi, Robert Bergquist, Amin Golabpour, Kamran Ghaffarzadegan, Fatemeh Rahmatinejad, Reza Darrudi, Saeid Eslami
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
BMC Cancer
BMC Cancer
Background The incidence rate of colorectal cancer (CRC) is increasing among patients below 50 years of age. The reason for this is unclear, but could have to do with the fact that indicative variables, such as tumour location, gender preference and
Autor:
Hiroyuki, Matsubayashi, Satomi, Higashigawa, Yoshimi, Kiyozumi, Takuma, Oishi, Keiko, Sasaki, Hirotoshi, Ishiwatari, Kenichiro, Imai, Kinichi, Hotta, Yohei, Yabuuchi, Kazuma, Ishikawa, Tatsunori, Satoh, Hiroyuki, Ono, Akiko, Todaka, Takeshi, Kawakami, Hiromichi, Shirasu, Hirofumi, Yasui, Teichi, Sugiura, Katsuhiko, Uesaka, Hiroyasu, Kagawa, Akio, Shiomi, Nobuhiro, Kado, Yasuyuki, Hirashima, Yoshio, Kiyohara, Etsuro, Bando, Masashi, Niwakawa, Seiichiro, Nishimura, Takeshi, Aramaki, Nobuaki, Mamesaya, Hirotsugu, Kenmotsu, Yasue, Horiuchi, Masakuni, Serizawa
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
BMC Cancer
BMC Cancer
Background Microsatellite instability (MSI) is a key marker for predicting the response of immune checkpoint inhibitors (ICIs) and for screening Lynch syndrome (LS). Aim This study aimed to see the characteristics of cancers with high level of MSI (M
Autor:
Yunlong Jia, Cong Tian, Hongyan Wang, Fan Yu, Wei Lv, Yuqing Duan, Zishuo Cheng, Xuexiao Wang, Yu Wang, Tianxu Liu, Jiali Wang, Lihua Liu
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-22 (2021)
Molecular Cancer
Molecular Cancer
Background Cis-diamminedichloro-platinum (CDDP)-based chemotherapy regimens are the most predominant treatment strategies for patients with esophageal squamous cell carcinoma (ESCC). Dysregulated long non-coding RNAs (lncRNAs) contribute to CDDP resi
Autor:
Masahiro Tanji, Tomoko Shofuda, Susumu Miyamoto, Yoshiki Arakawa, Ema Yoshioka, Sachiko Minamiguchi, Yasuhide Makino, Masayuki Mano, Takeshi Kawauchi, Takanori Hirose, Masahiro Nonaka, Yohei Mineharu, Yoshiko Okita, Daisuke Kanematsu, Yoshinori Kodama, Yonehiro Kanemura
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Cancer
BMC Cancer
Background Mutations in driver genes such as IDH and BRAF have been identified in gliomas. Meanwhile, dysregulations in the p53, RB1, and MAPK and/or PI3K pathways are involved in the molecular pathogenesis of glioblastoma. RAS family genes activate
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background Previous research found that the cancer history of an individual’s sibling may be a better indicator than that of the parents. We aim to provide recommendations for opportunistic screening for individuals whose sibling had been diagnosed
Autor:
Koichi Takeda, Brian Hayama, Toshiharu Sasaki, Kenji Nakano, Daisuke Ohkushi, Kosuke Hoashi, Koh Okamoto, Taisuke Enokida, Sohei Harada
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background Pneumocystis jirovecii pneumonia (PCP)-related risk factors among patients with solid tumors are not completely defined. Thus, we aimed to characterize PCP cases with underlying solid tumors, to highlight the factors contributing to its de
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
BMC Cancer
BMC Cancer
BackgroundProsthesis-related complications, after knee reconstruction with endoprosthesis during operation for tumors around the knee, remain an unresolved problem which necessitate a revision or even an amputational surgery. The purpose of the curre
Autor:
Yongqiang Zheng, Haotian Ma, Pengcheng Yang, Ying Chen, Yun Yang, Kaixu Yu, Jiayuan Chen, Bian Wu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background Receiving a cancer diagnosis may trigger immediate fatal non-cancer health outcomes in addition to dying of cancer itself. We aim to investigate the full pattern of non-cancer deaths in patients within a year of a cancer diagnosis. Methods
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background There are no epidemiological studies describing rare cancers in Western Australia (WA). We aimed to fill this gap by estimating the incidence and five-year survival of rare, less common and common cancers in WA, based on definitions for ra
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background Malignant melanoma of the female genital tract is relatively uncommon and accounts for 3–7% of all melanoma localizations. This study aimed to identify driver genes in melanoma of the female genital tract with the purpose of enhancing un